4215 5 (Onglyza 5 mg)
Generic Name: saxagliptin
Pill imprint 4215 5 has been identified as Onglyza 5 mg.
Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 4215 5
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00310-6105||AstraZeneca Pharmaceuticals LP|
More about Onglyza (saxagliptin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 13 Reviews – Add your own review/rating
- Drug class: dipeptidyl peptidase 4 inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.